Bausch + Lomb (BLCO) Competitors

Smith & Nephew (NYSE:SNN) and Bausch + Lomb (NYSE:BLCO) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their earnings, dividends, institutional ownership, media sentiment, risk, profitability, analyst recommendations, valuation and community ranking.

Which has stronger earnings and valuation, SNN or BLCO?

Smith & Nephew has higher revenue and earnings than Bausch + Lomb. Bausch + Lomb is trading at a lower price-to-earnings ratio than Smith & Nephew, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Smith & Nephew	$5.81B	2.15	$263M	$2.16	13.22
Bausch + Lomb	$4.79B	0.86	-$317M	-$0.91	-12.80

Does the MarketBeat Community prefer SNN or BLCO?

Smith & Nephew received 408 more outperform votes than Bausch + Lomb when rated by MarketBeat users. Likewise, 54.10% of users gave Smith & Nephew an outperform vote while only 41.41% of users gave Bausch + Lomb an outperform vote.

Company	Underperform	Outperform
Smith & Nephew	Outperform Votes 449 54.10%	Underperform Votes 381 45.90%
Bausch + Lomb	Outperform Votes 41 41.41%	Underperform Votes 58 58.59%

Does the media favor SNN or BLCO?

In the previous week, Bausch + Lomb had 11 more articles in the media than Smith & Nephew. MarketBeat recorded 20 mentions for Bausch + Lomb and 9 mentions for Smith & Nephew. Smith & Nephew's average media sentiment score of 0.87 beat Bausch + Lomb's score of 0.04 indicating that Smith & Nephew is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Smith & Nephew	6 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Bausch + Lomb	3 Very Positive mention(s)	4 Positive mention(s)	4 Neutral mention(s)	3 Negative mention(s)	0 Very Negative mention(s)	Neutral

Which has more volatility and risk, SNN or BLCO?

Smith & Nephew has a beta of 0.71, suggesting that its share price is 29% less volatile than the S&P 500. Comparatively, Bausch + Lomb has a beta of 0.54, suggesting that its share price is 46% less volatile than the S&P 500.

Do insiders & institutionals have more ownership in SNN or BLCO?

25.6% of Smith & Nephew shares are held by institutional investors. Comparatively, 11.1% of Bausch + Lomb shares are held by institutional investors. 1.0% of Smith & Nephew shares are held by company insiders. Comparatively, 0.8% of Bausch + Lomb shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Is SNN or BLCO more profitable?

Smith & Nephew has a net margin of 0.00% compared to Bausch + Lomb's net margin of -6.62%. Bausch + Lomb's return on equity of 3.35% beat Smith & Nephew's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Smith & Nephew	N/A	N/A	N/A
Bausch + Lomb	-6.62%	3.35%	1.66%

Do analysts rate SNN or BLCO?

Smith & Nephew currently has a consensus price target of $28.00, indicating a potential downside of 1.91%. Bausch + Lomb has a consensus price target of $16.14, indicating a potential upside of 38.53%. Given Bausch + Lomb's stronger consensus rating and higher possible upside, analysts clearly believe Bausch + Lomb is more favorable than Smith & Nephew.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Smith & Nephew	0 Sell rating(s)	6 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Bausch + Lomb	1 Sell rating(s)	7 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.25

Summary

Smith & Nephew beats Bausch + Lomb on 12 of the 18 factors compared between the two stocks.